Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 2335Neoplasms 1695Prostatic Neoplasms 1186Lung Neoplasms 915Colorectal Neoplasms 863Carcinoma, Non-Small-Cell Lung 855Leukemia, Myeloid, Acute 590Pancreatic Neoplasms 573Multiple Myeloma 543Carcinoma, Hepatocellular 510Brain Neoplasms 498Neoplasm Metastasis 460Head and Neck Neoplasms 448Melanoma 410Ovarian Neoplasms 407Precursor Cell Lymphoblastic Leukemia-Lymphoma 397Glioblastoma 386Stomach Neoplasms 376Squamous Cell Carcinoma of Head and Neck 361Uterine Cervical Neoplasms 355Rectal Neoplasms 339Recurrence 332Colonic Neoplasms 323Sarcoma 322Hematologic Neoplasms 322Lymphoma 320Triple Negative Breast Neoplasms 291Carcinoma, Renal Cell 282Urinary Bladder Neoplasms 279Glioma 269

Interventions

Pluvicto 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × High-Risk Localized Prostate Cancer × 1 year × Clear all
NCT07550517 2026-04-24

PSMA-High: EBRT/ PSMA617/ ADT vs. EBRT/ ADT

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Not yet recruiting
60 enrolled
Genitourinary

High-Risk Localized Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡